Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
sunclouds's Profile
Displaying 201-250 of 455 result(s).
CYDY CytoDyn Inc
01/27/2021 8:21:13 AM
The data management team does not w (7)
CYDY CytoDyn Inc
01/13/2021 7:08:02 AM
Ohm20 I am simply tying to explain (10)
CYDY CytoDyn Inc
01/12/2021 10:47:56 PM
I don't agree, the data is provided (1)
CYDY CytoDyn Inc
01/12/2021 10:45:49 PM
In my experience with being a proje (1)
CYDY CytoDyn Inc
12/15/2020 11:27:11 PM
The DMSC determines if a trial shou (4)
CYDY CytoDyn Inc
12/10/2020 9:14:30 PM
No need for DSMC review if trial if (3)
CYDY CytoDyn Inc
12/03/2020 9:18:05 AM
The FDA can only approve what is pr (7)
CYDY CytoDyn Inc
11/25/2020 2:16:38 PM
Wasn't Itolizumab, another mab from (1)
CYDY CytoDyn Inc
11/23/2020 11:43:52 AM
No mention of US HIV timeline so as
CYDY CytoDyn Inc
11/12/2020 8:59:07 PM
I would assume that it would have b
CYDY CytoDyn Inc
11/12/2020 8:49:42 AM
The info for the last loan is in SE (1)
CYDY CytoDyn Inc
11/09/2020 7:40:02 PM
That Lilly EUA is so weak and they (3)
CYDY CytoDyn Inc
11/05/2020 8:33:49 PM
FDA means FDA - not amarex IMO (1)
CYDY CytoDyn Inc
11/05/2020 8:29:47 PM
It is shocking that the clinical te (5)
CYDY CytoDyn Inc
10/27/2020 3:23:00 PM
In the US, the price for HIV will b
CYDY CytoDyn Inc
10/26/2020 3:04:50 PM
Phase 4 studies are post approval s (2)
CYDY CytoDyn Inc
10/26/2020 8:13:58 AM
There has been discussion about the (2)
CYDY CytoDyn Inc
10/21/2020 7:51:13 AM
Ohm20 The effective dilution would (2)
CYDY CytoDyn Inc
10/20/2020 10:59:38 AM
The fair market values varies based
CYDY CytoDyn Inc
10/20/2020 10:41:54 AM
Clinical trial reimbursements rates (1)
CYDY CytoDyn Inc
10/20/2020 10:32:38 AM
They did mention that sites were bu (1)
CYDY CytoDyn Inc
10/04/2020 11:40:00 AM
Will the BP manuscript be fully pee
CYDY CytoDyn Inc
09/29/2020 10:34:59 AM
Lagrange Your sarcastic posts warra
CYDY CytoDyn Inc
09/26/2020 1:24:44 PM
There is one thing that cam newton (3)
CYDY CytoDyn Inc
09/26/2020 1:09:31 PM
The dr been question about the pape (2)
CYDY CytoDyn Inc
09/24/2020 9:34:39 AM
I would say the 30% discount would (2)
CYDY CytoDyn Inc
09/23/2020 10:49:02 AM
Cydy should consider offering an in (1)
CYDY CytoDyn Inc
09/23/2020 8:29:02 AM
I double checked and see the link n
CYDY CytoDyn Inc
09/23/2020 5:57:44 AM
The PR was missing the link to the (2)
CYDY CytoDyn Inc
09/16/2020 3:38:35 PM
As far as i know is we only have on
CYDY CytoDyn Inc
09/16/2020 3:15:03 PM
None before open I am hoping for so
CYDY CytoDyn Inc
09/16/2020 9:32:39 AM
Companies do not need to rely only (6)
CYDY CytoDyn Inc
09/15/2020 9:32:36 AM
From the press resease this morning (3)
CYDY CytoDyn Inc
09/14/2020 8:42:35 PM
There is no way any IMO any company (7)
CYDY CytoDyn Inc
09/13/2020 8:25:56 PM
Thanks for all of the public and pr (4)
CYDY CytoDyn Inc
09/13/2020 12:37:47 PM
Board help please! My mother just c (1)
CYDY CytoDyn Inc
09/04/2020 11:35:43 AM
Looking forward to these yearly reu (2)
CYDY CytoDyn Inc
09/03/2020 12:28:59 PM
Reallypeople I think that you are i (1)
CYDY CytoDyn Inc
09/02/2020 9:35:55 PM
Fortuno If you just listen to the c (7)
CYDY CytoDyn Inc
09/01/2020 10:16:41 PM
JNCE got low royalty % from Gilead
CYDY CytoDyn Inc
08/31/2020 3:22:55 PM
Maybe they applied for the money Be (1)
CYDY CytoDyn Inc
08/30/2020 2:36:31 PM
I like the very soon timeframe for (1)
CYDY CytoDyn Inc
08/29/2020 8:40:25 PM
Cdiddy Great to have you back - nic (1)
CYDY CytoDyn Inc
08/28/2020 11:23:48 AM
The same team that hired an retaine (2)
CYDY CytoDyn Inc
08/28/2020 11:05:29 AM
Index guy Amarex has always been re (4)
CYDY CytoDyn Inc
08/27/2020 2:22:04 PM
Actually the article was on page B5 (1)
CYDY CytoDyn Inc
08/26/2020 9:26:14 PM
Disappointed In the WSJ. The last t (6)
CYDY CytoDyn Inc
08/26/2020 10:08:19 AM
Zadle I think we can all agree to d (2)
CYDY CytoDyn Inc
08/25/2020 1:38:19 PM
As we all know that is like saying (1)
CYDY CytoDyn Inc
08/25/2020 9:47:09 AM
If you read the NEWS study and look
Go to page:
  • << First
  • < Previous
  • 4
  • 5
  • Next >

Recent Articles

  • HashJ Expands Accessibility for XRP Investors with New Contracts
  • Trice Contracting Inc. Expands Services for Historic Preservation
  • Revolutionary Weight Loss Pill Offers New Hope for Obesity
  • Exploring the Future of Internet Connectivity with Starlink
  • Seize the Moment: Participate in Reckitt Benckiser Class Action
  • Reckitt Benckiser Securities Fraud Lawsuit Deadline Approaches
  • Therapy Ideas for Your Innovative Health and Wellness Center
  • Meta's Bold Move: Why Investing $250M in AI Talent Matters
  • Accessory Dwelling Unit Plans in 2025: Smart Designs for Purpose, Space & Long-Term Value
  • Impact of Tariff Loophole Elimination on Global Commerce
  • Berkshire Hathaway's $3.8 Billion Write-Down on Kraft Heinz
  • Unveiling Success: President Trump's Achievements This Week
  • Berkshire Hathaway's Caution as Cash Reserves Hit $344 Billion
  • Elon Musk Addresses Control Concerns Amid Shareholder Influence
  • Unlocking Fitness Franchise Opportunities: Your Guide to a Stronger Business Future
  • President Trump’s Vision: Turning America’s Aspirations into Reality
  • Home Sellers Adjust to Buyer Hesitation Amid Price Challenges
  • Two Smart Paths to Franchise Ownership: Medical and Mosquito Control Businesses
  • Investor Alert: Class Actions for Neogen, Alto, RxSight, and Replimune
  • TrimIQ UK Launch: A Revolutionary Approach to Wellness
  • Exploring Arialief: A Natural Solution for Nerve Pain Relief
  • Unlocking the Secrets of No Deposit Free Spins at Wild Casino
  • Sam Altman's Urgent Caution on AI Risks and Innovations
  • Matsato Knife Revolutionizes Culinary Tools in Key Markets
  • Discover the Benefits of Audizen Drops for Nerve Health
  • Niche Matters: How Focusing Drives RIA Growth and Client Loyalty
  • Significant Movement in Bitcoin as Long-Dormant Wallet Empties
  • Reddit Investors: Join the Class Action Against Fraud Today
  • Investor Alert: Securities Fraud Class Action Lawsuit Against Hims & Hers
  • Perplexity's Success: Aravind Srinivas Challenges Tech Titans
  • Insights from Bill Ackman: Investing During Market Uncertainty
  • Berkshire Hathaway Faces Challenges Amidst Market Uncertainty
  • Unveiling Underrated Stocks to Watch for Future Growth
  • Revolutionizing Connectivity: The Future of Starlink Technology
  • Understanding Your Rights as a Simulations Plus, Inc. Investor
  • Shiba Inu Coin Flourishes as HashJ Introduces New Contracts
  • Recent Stock Insights: Key Players in the Market Breakdown
  • Risetcar's Autonomous Taxis Set to Transform Jakarta's Transport
  • Pan-Mass Challenge: Cyclists Unite for Groundbreaking Research
  • Bitcoin Swift Presale Enters New Phase with Innovative AI Rewards
  • Celebrating Financial Health: Global Impact Champions Awards Launch
  • Avast Emerges as the Top Choice for Antivirus Software
  • FAA Implements Changes to Helicopter Routes after Tragedy
  • Navigating High-Beta Stocks: Echoes of the Dot-Com Boom
  • Understanding the Real Dynamics Behind Portfolio Performance
  • Overview of Financière de Tubize’s Half-Year Performance
  • Financière de Tubize Unveils Promising Financial Results for 2025
  • Legal Actions from Shareholders: Insights on Sarepta and Petco
  • Kuvi.ai Unveils Agentic Finance OS in Seed Funding Expansion
  • SHARC Energy Advancing Financing with New Convertible Debentures
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site